A clinical trial for efficacy and safety of carbon-ion radiotherapy on pelvic recurrent rectal cancer
- Conditions
- Recurrent rectal cancer
- Registration Number
- JPRN-UMIN000032650
- Lead Sponsor
- ational Institutes for Quantum and Radiological Science and Technology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 21
Not provided
1.Tumor exceeds 15 cm in greatest dimension 2. Subjects receiving other investigational agents they received chemotherapy within 4 weeks of CIRT3. they had an infection at the tumor site 4. The tumor is infiltrating the digestive tract or bladder 5. Prior radiation to the pelvis 6. resectable by radiographic 7. with distant metastasis 8. Active other cancer or within 2 years of disease free period after cancer treatment 9. serious complications 10. difficult to participate in clinical trials because of mental illness 11. Patients who doctors judged that clinical trial participation is inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method